Is a complete NSE/SHILPAMED research report available?

Question

Accepted Answer

No complete published report is available for nse/SHILPAMED (NSE/SHILPAMED) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Beta
Market cap	118.3B
Revenue (ttm)	15.4B
Net income (ttm)	2.4B
EPS (ttm)	₹12.4
P/E (trailing)	48.6x
P/E (forward)	45.1x
Dividend	₹0.50 (0.08%)
Volume	382,771

Metric	Value
Country	India
Country code	IN
Employees	998
Employees Change	-9%
Employees Change Percent	-0.89
Enterprise value	INR 124.4B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.93
Industry PE Fwd	34.64
Isin	INE790G01031
Last refreshed	2026-07-30
Market cap	INR 118.3B
Price	INR 605
Price currency	INR
Rev Per Employee	15,419,539.08x
Sector	Healthcare
Sector PE	46.52
Sector PE Fwd	37.94
Sic	2833
Symbol	nse/SHILPAMED
Website	https://www.vbshilpa.com

Metric	Value
Earnings Yield	2.06%
EV Earnings	51.13x
EV/EBIT	37.46x
EV/EBITDA	27.53x
EV/Sales	8.08x
FCF yield	-0.24%
Forward P/E	45.11x
P/B ratio	4.56x
P/E ratio	48.6x
P/S ratio	7.68x
PE Ratio10 Y	65.18x
PE Ratio3 Y	77.56x
PE Ratio5 Y	109.3x

Metric	Value
EBIT Margin	20.47%
EBITDA Margin	28.25%
Gross margin	70.08%
Gross Profit	INR 10.8B
Gross Profit Growth	29.33%
Gross Profit Growth Q	60.19%
Gross Profit Growth3 Y	22.18%
Gross Profit Growth5 Y	12.9%
Net Income	INR 2.4B
Net Income Growth	210.79%
Net Income Growth Q	642.91%
Net Income Growth Quarters	4%
Net Income Growth Years	3%
Net Income Growth5 Y	10.49%
Pretax Margin	19.19%
Profit Margin	15.81%
Profit Per Employee	INR 2.4M
Profitable Quarters	INR 12
Profitable Years	3
ROA	5.61
Roa5y	2.95
ROCE	11.02
ROE	9.82
Roe5y	3.47
ROIC	8.35
Roic5y	3.73

Metric	Value
Cagr10y	7.67%
Cagr15y	19.43%
Cagr1y	36.77%
Cagr3y	50.08%
Cagr5y	14.04%
Div CAGR10	6.16%
Div CAGR3	-3.13%
Div CAGR5	-13.79%
EPS Growth	209.6
EPS Growth Q	644.6
EPS Growth Quarters	4
EPS Growth Years	3
EPS Growth5 Y	6.54
OCF Growth	158.88%
OCF Growth10 Y	10.27%
OCF Growth3 Y	23.9%
OCF Growth5 Y	48.79%
Revenue Growth	19.49x
Revenue Growth Q	31.51x
Revenue Growth Quarters	11x
Revenue Growth Years	3x
Revenue Growth3 Y	13.53x
Revenue Growth5 Y	11.29x

NSE/SHILPAMED (NSE/SHILPAMED)

Coverage state: Market snapshot only — no published research

Generate the first NSE/SHILPAMED analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NSE/SHILPAMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/SHILPAMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NSE/SHILPAMED

Frequently asked questions

Metric	Value
Asset Turnover	INR 0.44
Assets	INR 37.1B
Cash	INR 451.8M
Current Assets	INR 11.1B
Current Liabilities	INR 8.5B
Debt	INR 6.6B
Debt EBITDA	INR 1.52
Debt Equity	INR 0.25
Debt FCF	INR -23.19
Equity	INR 25.9B
Interest Coverage	5.36
Liabilities	INR 11.1B
Long Term Assets	INR 26B
Long Term Liabilities	INR 2.7B
Net Cash	INR -6.1B
Net Cash By Market Cap	INR -5.2
Net Debt EBITDA	INR 1.41
Net Debt Equity	INR 0.24
Tangible Book Value	INR 19B
Tangible Book Value Per Share	INR 96.93
WACC	5.46

Metric	Value
Current ratio	1.31
Inventory Turnover	1.29
Net Working Capital	INR 6.9B
Quick ratio	0.67
Working Capital	INR 2.6B
Working Capital Turnover	INR 5.37

Metric	Value
Buyback Yield	-0.38%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.5
Dividend Years	1
Dividend Yield	0.08%
Ex Div Date	2025-09-17
Last Dividend	INR 0.5
Payout Ratio	4.02%

Metric	Value
10Y total return	109.45%
1Y total return	36.74%
200-day SMA	404.8
3Y total return	238.13%
50-day SMA	567.6
50-day SMA vs 200-day SMA	50over200
5Y total return	92.89%
All Time High	650
All Time High Change	-6.98%
All Time High Date	2026-07-14
All Time Low	22.52
All Time Low Change	2,585.08%
All Time Low Date	2011-12-19
ATR	23.39
Beta	0.2
Ch YTD	88.26
High	616.3
High52	650
High52 Date	2026-07-14
High52ch	-6.98%
Low	600.1
Low52	259.5
Low52 Date	2026-01-27
Low52ch	132.99%
Ma50ch	6.52%
Price vs 200-day SMA	49.35%
RSI	51.76
RSI Monthly	72.8
RSI Weekly	77.94
Sharpe ratio	0.8x
Sortino ratio	1.5
Total Return	-0.3%
Tr YTD	88.26
Tr15y	1,333.83%
Tr1m	5.77%
Tr1w	-5.53%
Tr3m	48.26%

Metric	Value
Analyst Count	3
Analyst Ratings	Buy
Operating Income	INR 3.1B
Operating Income Growth	61.2
Operating Income Growth Q	126.7
Operating Income Growth5 Y	21.54
Operating margin	20.47
Price target	INR 603
Price Target Change	INR -0.26

Metric	Value
Float	93,774,488%
Net Borrowing	710,000,000
Shares Insiders	49.53%
Shares Institutions	18.54%
Shares Qo Q	3.56%
Shares Yo Y	0.38%

Metric	Value
Average Volume	658,898.4x
Bv Per Share	132.5
CAPEX	INR -3.7B
Ch10y	106.3
Ch15y	1,289.9
Ch1m	5.77
Ch1w	-5.53
Ch1y	36.57
Ch3m	48.26
Ch3y	237.7
Ch5y	91.74
Ch6m	120.9
Change	-0.1%
Change From Open	-1.21
Close	605.2
Days Gap	1.12
Depreciation Amortization	1,197,200,000
Dollar Volume	231,423,346.6
Earnings Date	2026-08-05
EBIT	INR 3.1B
EBITDA	INR 4.3B
EPS	INR 12.44
F Score	7
FCF	INR -284.5M
FCF EV Yield	-0.23x
Financing CF	136,200,000
Fiscal Year End	March
Founded	1,987
Goodwill	468,600,000
Graham Number	192.56403
Graham Upside	-68.15
Income Tax	INR 519.9M
Investing CF	-3,259,200,000
Is Primary Listing	0
Last Earnings Date	2026-05-22
Last Report Date	2026-03-31
Last Split Date	2025-10-03
Last Split Type	Forward
Lynch Fair Value	INR 130
Lynch Upside	-78.42
Ma150	421.2
Ma150ch	43.53%
Ma20	616.4
Ma20ch	-1.92%
Net CF	166,100,000
Next Earnings Date	2026-08-05
Open	612
P OCF Ratio	34.56
Payment Date	2025-10-23
Position In Range	27.78
Ppne	17,821,000,000
Price Date	2026-07-29
Price EBITDA	INR 27.2
Ptbv Ratio	6.24
Relative Volume	0.52x
Revenue	15,388,700,000x
Tax By Revenue	3.38x
Tax Rate	17.6%
Tr6m	120.9%
Volume	382,771